The Recombinant Factor C Assay Market was valued at USD 500 million in 2025 and is projected to grow to USD 1.2 billion by 2035, registering a CAGR of 9.1% during the forecast period. This significant growth trajectory reflects the essential role of recombinant Factor C assays in addressing the demand for accurate endotoxin testing, improved biopharmaceutical safety, and sustainable testing...